Rhophylac 300 MCG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26FRM3Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,378
Award facts
- Contract value 100% obligated
- $1,377.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp on July 29, 2026, with a ceiling value of $1,377.90 for RHOPHYLAC 300 MCG/2 ML syringe 2ML, identified as item 4572520119. Pricing is firm fixed price, and the order carries an ultimate completion date of August 19, 2026. Place of performance is Conshohocken, PA 19428, USA. No set-aside was used, and the prime holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26FRM3Y?
SPE2DR26FRM3Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2026.
How much is contract SPE2DR26FRM3Y worth?
The government has obligated $1,378 on SPE2DR26FRM3Y.
Is contract SPE2DR26FRM3Y an order under another contract?
Yes. SPE2DR26FRM3Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FRM3Y competed?
The extent of competition for SPE2DR26FRM3Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award